|
| 37550442 | The Association of Subspecialty and Sex with Industry Payments to Internal Medicine Physicians Who Recently Completed Training. | J Gen Intern Med | 2024 |
| 37850574 | Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer. | J Pathol | 2024 |
| 36372998 | Presence of cells in the polyaneuploid cancer cell (PACC) state predicts the risk of recurrence in prostate cancer. | Prostate | 2023 |
| 37843861 | Industry Payments Received by Residents During Training. | JAMA Netw Open | 2023 |
| 37722985 | Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassification. | Urol Oncol | 2023 |
| 37040112 | Trainee Physician Milestone Ratings and Patient Complaints in Early Posttraining Practice. | JAMA Netw Open | 2023 |
| 37307876 | Predicting Prostate Cancer Molecular Subtype With Deep Learning on Histopathologic Images. | Mod Pathol | 2023 |
| 36921737 | Human C1q Tumor Necrosis Factor 8 (CTRP8) defines a novel tryptase+ mast cell subpopulation in the prostate cancer microenvironment. | Biochim Biophys Acta Mol Basis Dis | 2023 |
| 36585434 | MyProstateScore in men considering repeat biopsy: validation of a simple testing approach. | Prostate Cancer Prostatic Dis | 2023 |
| 36868922 | Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer. | Eur Urol Oncol | 2023 |
| 36828362 | ERG Status at the Margin Is Associated With Biochemical Recurrence After Radical Prostatectomy With Positive Surgical Margins. | Mod Pathol | 2023 |
| 36629377 | AUA-Recommended Antibiotic Prophylaxis for Primary Penile Implantation Results in a Higher, Not Lower, Risk for Postoperative Infection: A Multicenter Analysis. Letter. | J Urol | 2023 |
| 36073925 | Clinical Significance of Perineural Invasion in Men With Grade Group 1 Prostate Cancer on Active Surveillance. | J Urol | 2023 |
| 34049847 | Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma. | Eur Urol Oncol | 2022 |
| 35478055 | Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer. | Med Oncol | 2022 |
| 35638091 | Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race. | Eur Urol Open Sci | 2022 |
| 36349916 | Reply by Authors. | J Urol | 2022 |
| 36260332 | Trends in Industry Payments to Physicians in the First 6 Years After Graduate Medical Training. | JAMA Netw Open | 2022 |
| 35947519 | Editorial Comment. | J Urol | 2022 |
| 36006048 | Cell Cycle Progression Score, but Not Phosphatase and Tensin Homolog Loss, Is an Independent Prognostic Factor for Metastasis in Intermediate- and High-risk Prostate Cancer in Men Treated With and Without Salvage Radiotherapy. | J Urol | 2022 |
| 35131885 | The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 34906585 | Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need. | Urology | 2022 |
| 35176252 | Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis. | Hum Pathol | 2022 |
| 34582341 | Chronic pain associated with penile prostheses may persist despite revision or explantation. | Can Urol Assoc J | 2022 |
| 34426176 | Gender-specific Stratification of Survival Following Immune Checkpoint Inhibitor Therapy Based on Intratumoral Expression of a B cell Gene Signature. | Eur Urol Oncol | 2022 |
| 33000302 | Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort. | Eur Radiol | 2021 |
| 33596212 | Feasibility of integrating canine olfaction with chemical and microbial profiling of urine to detect lethal prostate cancer. | PLoS One | 2021 |
| 33531653 | A comparative study of PCS and PAM50 prostate cancer classification schemes. | Prostate Cancer Prostatic Dis | 2021 |
| 34902034 | Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer. | JAMA Netw Open | 2021 |
| 34653184 | External validation of the priapism impact profile in a Jamaican cohort of patients with sickle cell disease. | PLoS One | 2021 |
| 34078583 | Volume-outcome relationships for kidney cancer may be driven by disparities and patient risk. | Urol Oncol | 2021 |
| 33958731 | Mapping PSA density to outcome of MRI-based active surveillance for prostate cancer through joint longitudinal-survival models. | Prostate Cancer Prostatic Dis | 2021 |
| 34196715 | Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features. | JAMA Netw Open | 2021 |
| 34003011 | Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies. | J Urol | 2021 |
| 34086480 | Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death. | J Clin Oncol | 2021 |
| 34191807 | GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United States. | PLoS One | 2021 |
| 33998599 | Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer. | J Clin Invest | 2021 |
| 33080150 | Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach. | J Urol | 2021 |
| 33037017 | Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer. | Clin Cancer Res | 2021 |
| 30640196 | Urinary Incontinence and Pelvic Organ Prolapse Knowledge, Care-Seeking, and Embarrassment in Women Planning Bariatric Surgery: A Cross-sectional Study. | Female Pelvic Med Reconstr Surg | 2020 |
| 31704140 | The incidence, predictors, and survival of disappearing small renal masses on active surveillance. | Urol Oncol | 2020 |
| 31639200 | Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts. | Cancer | 2020 |
| 32043362 | Reducing preoperative blood orders and costs for radical prostatectomy. | J Comp Eff Res | 2020 |
| 32694154 | Genomic and Clinicopathologic Characterization of ATM-deficient Prostate Cancer. | Clin Cancer Res | 2020 |
| 32444264 | Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial. | Eur Urol | 2020 |
| 32360049 | Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. | Eur Urol | 2020 |
| 32231245 | Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier. | Prostate Cancer Prostatic Dis | 2020 |
| 31611635 | A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer. | Prostate Cancer Prostatic Dis | 2020 |
| 31437120 | Urinary Continence Outcomes in Classic Bladder Exstrophy: A Long-Term Perspective. | J Urol | 2020 |
| 30279579 | PTEN status assessment in the Johns Hopkins active surveillance cohort. | Prostate Cancer Prostatic Dis | 2019 |